Oral Biologics Market: Current Analysis and Forecast (2022-2028)

Report Description

The global oral biologics market is expected to grow at a significant rate of around 22% during the forecast period. Genetic engineering is used to produce biological medicines, which are made of proteins derived from human genes and these drugs are also derived from a variety of natural sources. These sources include blood and blood components, gene therapy, somatic cells, tissues, and recombinant therapeutic proteins. For therapeutic interventions in conditions including metabolic disease, aging, and inflammatory disorders, biologics is currently one of the most promising approaches. For chronic diseases, oral delivery of such medications has long been recognized as an important goal.

Oral product efficacy for Crohn’s and rheumatoid arthritis attracts more moderate patients to the biologics drug and new treatments which will contribute to the growth of the market. For instance, according to the National Institutes of Health (NIH), out of every 100,000 people, 71 are diagnosed with rheumatoid arthritis every year and around 1.5 million Americans have rheumatoid arthritis. Other factors such as the growing prevalence of chronic diseases, increasing government initiatives, technological advancements in research & development by major key players, and increased availability of advanced diagnostics are expected to uplift the oral biologics market growth. For instance, according to the world health organization (WHO), chronic disease prevalence is expected to rise by 57% by 2020.

Novo Nordisk A/S; Biocon; Oramed; Rani Therapeutics; EnteraBio Ltd.; AbbVie Inc.; Enteris BioPharma Inc.; Chiasma, Inc.; Allena Pharmaceuticals; Lilly are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst drug class, glucagon-like peptide 1 (GLP-1) receptor agonist category to witness robust CAGR during the forecast period”

Based on drug class, the market is segmented into glucagon-like peptide 1 (GLP-1) receptor agonist, recombinant enzyme, somatostatin analogue, guanylate cyclase-c agonist, hormone, and others. The glucagon-like peptide 1 (GLP-1) receptor agonist category holds the major market share during the forecast period owing to the rising product approvals, product launches, partnerships, collaborations, mergers & acquisitions by key players, and r&d activities are expected to drive the market growth over the forecast period. For instance, in December 2020, Entera Bio Ltd. announced that the U.S. Food Drug and Administration had revived the company’s Investigational New Drug (IND) application for EB613, orally delivered human parathyroid hormone (1-34) or PTH, for the treatment of osteoporosis patients.

“Amongst disease indication, the diabetes category held a significant share in the market in 2020”

On the basis of disease indication, the market is categorized into diabetes, hyperoxaluria, acromegaly, irritable bowel syndrome (IBS), chronic idiopathic constipation (CIC), and others. Among these, the diabetes category held a significant share of the market in 2020. This is mainly due to the increasing prevalence of type 1 diabetes globally and the rising prevalence of obesity will drive the segmental growth during the forecast period. For instance, as per the International Diabetes Federation (IDF), around 1.2 million youngsters and youths have type 1 diabetes in 2021.

“North America to hold a significant share in the market”

For a better understanding of the market adoption of the oral biologics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, and rising incidences of chronic diseases such as cancer, autoimmune diseases, diabetes, arthritis, Alzheimer’s disease, and chronic kidney disease will contribute to the growth of the market. For instance, according to GLOBOCAN 2020, the number of new cancer cases diagnosed was 2,281,658 in the U.S. in 2020. Furthermore, rising investment in research and development activities by the key industry players and an increasing pipeline of products & new product launches in the market are also driving the market growth.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global oral biologics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Oral Biologics Market Analysis (2022-2028)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global oral biologics market were the three major steps undertaken to create and analyze the adoption of oral biologics markets in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global oral biologics market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the oral biologics market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the oral biologics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as drug class, disease indication, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the oral biologics market. Further, we conducted factor analysis using dependent and independent variables such as various drug class, disease indication, and distribution channels of oral biologics markets. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the oral biologics market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global oral biologics market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the oral biologics market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global oral biologics market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global oral biologics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of drug class, disease indication, and distribution channel in the global oral biologics market.

The main objective of the Global Oral Biologics Market Study

The current & future market trends of the global oral biologics market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the oral biologics market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of drug class, disease indication, and distribution channel.
• Define and analysis of the regulatory framework for the oral biologics market
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the oral biologics market for the major region.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
• Company profiles of the oral biologics market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team